Technological advancements have significantly impacted the business and economy today, leading to notable growth in India. The country's expanding landscape of startups is focused on establishing a robust ecosystem for entrepreneurship and innovation. Despite the increasing number of individuals venturing into entrepreneurship, successfully managing an organization in a dynamic and highly competitive market like India necessitates exceptional management skills and business acumen. Notably, India is up for boosting management education too. Standing tall in the management education space, IIMs are a beacon of excellence offering the best (undergraduate, postgraduate, doctoral, and executive programs) education to aspirants looking ahead to excel in business & entrepreneurship.

Today, many alumni from the Indian Institutes of Management (IIM) have made a significant impact in the business world, specializing in areas such as HR, finance, accounting, marketing, economics, and others. Today, we are here to celebrate another outstanding individual, Abhishek Mittal, who serves as the Managing Director of Mikayla Life Sciences. Abhishek is a B.Tech and an MBA in Marketing from IIM, Kozhikode. He has leveraged his educational background to significantly influence his entrepreneurial journey.

While his analytical skills have facilitated in-depth explorations of pharmaceutical manufacturing processes, identifying areas for enhancement to achieve superior outcomes; his strategic acumen has been instrumental in driving business expansion and scalability while effectively addressing setbacks. Notably, his exposure to esteemed organizations such as HUL, ITC, Cognizant, and Unilever has garnered him industry recognition and confidence. Formidably, today it is his robust business acumen, problem-solving skills, and technical & analytical knowledge that empower him to overcome new challenges and pursue continuous growth, pushing the boundaries of success.

The Entrepreneurial Drive

Hailing from a multi-generational business background, Abhishek since always holds a deep fascination for entrepreneurship. Hence, his perspective on entrepreneurship has always been framed not by the question of whether, but rather by the inevitability of its pursuit. His intrinsic entrepreneurial drive has consistently impelled him to innovate and address tangible societal issues from their very core. Well, it was the prevailing paradox

of widespread healthcare availability juxtaposed with a dearth of quality healthcare that served as the impetus for Abhishek's foray into the pharmaceutical sphere. Founding Mikayla Life Sciences, he endeavors to effectuate positive change by ensuring universal access to affordable, high-quality pharmaceuticals. This endeavor underscores the paramount importance of unwavering perseverance and adaptive acumen within the pharmaceutical landscape.

Mikayla Life Sciences, based in Panchkula, Chandigarh, is a leading company that manufactures and supplies a wide range of pharmaceuticals to semi regulated and non-regulated markets across the globe. The company is committed to providing world-class quality pharma supplies at competitive pricing to all and thus is constantly exploring new therapeutic segments to expand its product portfolio. Well, the establishment of Mikayla posed initial challenges and entailed risks in establishing credibility within a highly competitive market. Issues such as supply chain disruptions and regulatory hurdles persisted, but Abhishek navigated through them by adhering to Mikayla's core values and prioritizing the cultivation of robust relationships with healthcare professionals. Additionally, a focus on stringent quality control and investment in ethical marketing strategies proved instrumental in carving out a niche for the firm in the market.

The strategic move into the cardiabetic segment marked a turning point for Mikayla, as many companies exhibit reluctance to venture into this area. Given the critical and life-saving nature of cardiabetic drugs, stringent quality controls are imperative. Establishing trust with clientele is of paramount importance in this segment. Despite the challenges, Mikayla's confidence in its cardiabetic product, coupled with extensive research and development, facilitated a strong entry into this segment, resulting in market recognition. Subsequently, this success facilitated the firm's exploration into other segments, such as antibiotics, derma, kinase, and periodic, with greater ease. Today Mikayla Life Sciences has earned the reputation of a global manufacturer of high quality medicines and pharmaceutical products.

Abhishek's owns a collaborative and vision-driven leadership style, and thus is empowering his team through a culture of ownership and accountability, fostering innovation and alignment with the company's vision. Mikayla entrusts team members with projects and motivates them to deliver their best, aiming to cultivate in-house experts pivotal to the company's future success. To stay updated with market trends and technology, Mikayla maintains direct communication with clients and key stakeholders. The firm has a dedicated team for monitoring national and international market trends, prioritizing continuous learning and research.

Mikayla’s focus on leveraging advanced production technologies, adhering to regulatory guidelines, and active participation in exhibitions and conferences reflects its commitment to staying ahead in the industry. Abhishek strongly believes in giving back and has tried to instill the same values in his venture. Mikayla is actively involved in corporate social responsibility endeavors, focusing on aiding the underprivileged and impoverished through the organization of complimentary health camps, dispensation of cost-free medications, and provision of complimentary health examinations.

Looking forward, he envisions Mikayla Life Sciences to expand into international markets while upholding its commitment to quality and ethical practices. Its plan for growth involves increasing the production capacity, completing R&D, and collaborating with strategic partners worldwide. Mikayla Life Sciences’ goal is to enter the global market and establish a strong presence in the pharmaceutical industry, with the aim of making healthcare accessible not only in India but also worldwide. Currently, the firm is in the final stages of launching itself internationally and exporting its products to a couple of countries.

Abhishek asserting that acceptance of failure is an integral part of the entrepreneurial journey avers, "Stay true to your values, be patient, and not fear failure. Entrepreneurship is a marathon, not a sprint. Learn from your failures and surround yourself with people who believe in your vision, as compromising on your vision will ultimately affect your culture”.